Clinical Trials Browser

OTHER_GOV × Melanoma × tremelimumab × Clear all

NCT05928962 2023-07-10

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Phase 1 Unknown

Melanoma